Safety and efficacy of eculizumab in the prevention of antibody-mediated rejection in living-donor kidney transplant recipients requiring desensitization therapy: A randomized trial

C10-001 Study Group

Research output: Contribution to journalArticle

15 Scopus citations

Fingerprint Dive into the research topics of 'Safety and efficacy of eculizumab in the prevention of antibody-mediated rejection in living-donor kidney transplant recipients requiring desensitization therapy: A randomized trial'. Together they form a unique fingerprint.

Medicine & Life Sciences